Medical devices, healthcare technology and the business of care
510(k) clearance · K252923

IASIS i2 Relaxation Neurofeedback System

Iasis Technologies · Decision date Mar 13, 2026

FDA DECISIONK252923

What did the FDA decide?

FDA records K252923 as a 510(k) premarket notification, with a decision dated Mar 13, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Mar 13, 2026

FDA source record

Regulatory record facts

Identifier
K252923
Regulatory pathway
510(k) premarket notification
Product code
Not reported
Decision code
SESE
Decision date
Mar 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

Product code
Not reported

FDA decision timeline

  1. K252923 received

    Application receipt date recorded by FDA.

  2. K252923 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Iasis Technologies

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Murrieta, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records
K252923: IASIS i2 Relaxation Neurofeedback System | MedtechLedger